Immunization News and Research

RSS

New technology could protect against different coronavirus variants

The SARS-CoV-2 virus that is causing the COVID-19 pandemic is just one of many different viruses in the coronavirus family.

13 Jan 2021

Will the Pfizer–BioNTech vaccine be effective against the new N501Y SARS-CoV-2 variant?

Researchers from Pfizer and the University of Texas, USA, have presented evidence showing that people in a previously reported trial of the mRNA-based COVID-19 vaccine, BNT162b2 – commonly known as the Pfizer-BioNTech COVID-19 vaccine – had equivalent neutralizing titers to the N501 and Y501 viruses.

12 Jan 2021

Study supports continuing phase 3 trials of Ad26.COV2.S SARS-CoV-2 vaccine

An international team of researchers has provided further evidence to confirm the immunogenicity and efficacy of a recombinant adenovirus vaccine currently being tested in phase 3 trials for its ability to protect against infection with severe acute respiratory coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

11 Jan 2021

Is your covid vaccine venue prepared to handle rare, life-threatening reactions?

As the rollout of covid-19 vaccines picks up across the U.S., moving from hospital distribution to pharmacies, pop-up sites and drive-thru clinics, health experts say it's vital that these expanded venues be prepared to handle rare but potentially life-threatening allergic reactions.

11 Jan 2021

Single-dose nanoparticle COVID-19 vaccine elicits virus-neutralizing antibody response in mice

Across the world, health care workers and high-risk groups are beginning to receive COVID-19 vaccines, offering hope for a return to normalcy amidst the pandemic.

8 Jan 2021

As the vulnerable wait, some political leaders’ spouses get covid vaccines

With supplies of covid-19 vaccines scarce, a federal advisory panel recommends first putting shots into the arms of health care workers, who keep the nation's medical system running, and long-term care residents most likely to die from the coronavirus.

8 Jan 2021

Is one-dose COVID-19 vaccination better than two?

A recent study published on the preprint server medRxiv in December 2020 reflects on the possibility of using a single-dose vaccine regimen to accomplish large-scale vaccination as early as possible.

6 Jan 2021

Low acceptance of COVID-19 vaccine among healthcare workers in USA

A recent preprint research paper published on the medRxiv server in January 2021 reports that vaccine acceptance is low even among healthcare workers (HCWs) in the USA.

6 Jan 2021

Researchers receive £230,000 to develop world's first smart vaccine device

Researchers at Swansea University have received £230,000 to develop the world's first smart vaccine device that will both deliver the COVID-19 vaccine and measure its efficacy through monitoring the body's associated response.

6 Jan 2021

Evidence review: COVID-19 infections are generally 'mild' in children under five years

Babies and asymptomatic cases account for up to half of COVID-19 infections in the under-five age group, which has implications for vaccination programs, a new UNSW study has found.

6 Jan 2021

Modified Vaccinia Ankara model vaccine prevents COVID-19 in transgenic mice study

A new study shows the effectiveness of a novel recombinant vaccinia virus that expresses modified SARS-CoV-2 spike antigen, in preventing the replication of the virus in the respiratory tract of transgenic mice, and to prevent lethal disease.

6 Jan 2021

COVID-19 vaccination in UK may not lead to relaxation of control measures

Researchers have warned that early relaxation of coronavirus disease 2019 (COVID-19) control measures in the UK could lead to pronounced waves of further infection with the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

5 Jan 2021

Middle-aged adults with comorbidities high-risk category for COVID-19-related mortality in Mexican study

Researchers from Mexico demonstrate how they calculated age-stratified COVID-19 case fatality rates, years of life lost (YLL), and relative risk for 9 comorbidities and 23 comorbidity combinations in a retrospective study.

5 Jan 2021

WHO lists Comirnaty COVID-19 mRNA vaccine for emergency use

The World Health Organization (WHO) today listed the Comirnaty COVID-19 mRNA vaccine for emergency use, making the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the outbreak began a year ago.

3 Jan 2021

Research explores the cost-effectiveness of Sweden's national vaccination programs

Immunizing children against chickenpox would save money, but offering shingles vaccinations to all 65-year-olds would not. These are examples of findings in a University of Gothenburg thesis exploring the cost-effectiveness of Sweden's national vaccination programs.

23 Dec 2020

COVID vaccines appear safe and effective, but key questions remain

The recent rollout of two newly authorized COVID-19 vaccines is a bright ray of hope at the pandemic's darkest hour.

23 Dec 2020

Research finds persistent disparities in childhood vaccination

There has been continual progress in expanding immunization programs over time, but even before the COVID-19 pandemic, tens of millions of children worldwide were not receiving basic doses of vaccines.

22 Dec 2020

Inside the first chaotic days of the effort to vaccinate America

One tray of COVID-19 vaccine from pharmaceutical giant Pfizer contains 975 doses — way too many for a rural hospital in Arkansas.

22 Dec 2020

Enforcement can undermine voluntary motivation to comply with anti-Covid-19 policies

A study by the University of Konstanz shows that voluntary motivation to comply with anti-Covid-19 policies is relatively high in Germany, but can be undermined by enforcement - The consequence of this finding differs depending on the policy

22 Dec 2020

Large proportion of UK population hesitant over COVID-19 vaccine

Researcher Dr. Alex de Figueiredo from the London School of Hygiene and Tropical Medicine has conducted a study showing that a significant proportion of people in the UK will probably be reluctant to receive a vaccine to protect against coronavirus disease 2019 (COVID-19).

22 Dec 2020

Immunization News and Research

New technology could protect against different coronavirus variants

Will the Pfizer–BioNTech vaccine be effective against the new N501Y SARS-CoV-2 variant?

Study supports continuing phase 3 trials of Ad26.COV2.S SARS-CoV-2 vaccine

Is your covid vaccine venue prepared to handle rare, life-threatening reactions?

Single-dose nanoparticle COVID-19 vaccine elicits virus-neutralizing antibody response in mice

As the vulnerable wait, some political leaders’ spouses get covid vaccines

Is one-dose COVID-19 vaccination better than two?

Low acceptance of COVID-19 vaccine among healthcare workers in USA

Researchers receive £230,000 to develop world's first smart vaccine device

Evidence review: COVID-19 infections are generally 'mild' in children under five years

Modified Vaccinia Ankara model vaccine prevents COVID-19 in transgenic mice study

COVID-19 vaccination in UK may not lead to relaxation of control measures

Middle-aged adults with comorbidities high-risk category for COVID-19-related mortality in Mexican study

WHO lists Comirnaty COVID-19 mRNA vaccine for emergency use

Research explores the cost-effectiveness of Sweden's national vaccination programs

COVID vaccines appear safe and effective, but key questions remain

Research finds persistent disparities in childhood vaccination

Inside the first chaotic days of the effort to vaccinate America

Enforcement can undermine voluntary motivation to comply with anti-Covid-19 policies

Large proportion of UK population hesitant over COVID-19 vaccine

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News